Dokter Koen STAS: what changed
What changed
Dokter Koen STAS
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Net result for the year
€199,790
2024 · €191,436+€8,354
Equity
€965,454
2024 · €843,297+€122,157
Cash
€339,440
2024 · €250,031+€89,409
Balance sheet total
€1.1m
2024 · €883,960+€178,332
Largest movements
Assets
- Current investments +€100,000
up €100,000 (+16.7%), from €600,000 to €700,000
- Cash +€89,409
up €89,409 (+35.8%), from €250,031 to €339,440
mainly Net result for the year (+€199,790) and Other debts (+€51,935)
Equity and liabilities
- Reserves +€122,157
up €122,157 (+14.7%), from €830,897 to €953,054
- Other debts +€51,935
up €51,935 (+390%), from €13,313 to €65,248
Income statement
- Gross operating margin +€17,767
up €17,767 (+6.7%), from €263,726 to €281,493
- Taxes +€3,930
up €3,930 (+4.7%), from €84,112 to €88,041
- Financial income -€3,901
down €3,901 (-28.1%), from €13,886 to €9,985
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€191,436
Gross operating margin
+€17,767
Depreciation
+€104
Financial income
-€3,901
Financial charges
-€1,687
Taxes
-€3,930
Result 2025
€199,790
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€267,042
Investment
-€100,000
Financing
-€77,633
Cash 2024
€250,031
From operations (derived)
+€267,042
Net result for the year
+€199,790
Depreciation
+€835
Receivables within one year
+€10,264
Deferred charges and accrued income
-€23
Trade debts
+€1,717
Tax, wage and social debts
+€1,341
Other debts
+€51,935
Accrued charges and deferred income
+€1,182
Investment (derived)
-€100,000
Current investments
-€100,000
Financing
-€77,633
Contributions, distributions and other
-€77,633
Cash 2025
€339,440
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €883,960 | €1,062,293 | +€178,332 | +20.2% |
| Fixed assets | 21/28 | €835 | - | -€835 | |
| Tangible fixed assets | 22/27 | €835 | - | -€835 | |
| Plant, machinery and equipment | 23 | €835 | - | -€835 | |
| Current assets | 29/58 | €883,125 | €1,062,293 | +€179,167 | +20.3% |
| Amounts receivable within one year | 40/41 | €30,197 | €19,933 | -€10,264 | -34.0% |
| Other amounts receivable | 41 | €30,197 | €19,933 | -€10,264 | -34.0% |
| Current investments | 50/53 | €600,000 | €700,000 | +€100,000 | +16.7% |
| Cash at bank and in hand | 54/58 | €250,031 | €339,440 | +€89,409 | +35.8% |
| Deferred charges and accrued income | 490/1 | €2,897 | €2,920 | +€23 | +0.8% |
| Total equity and liabilities | 10/49 | €883,960 | €1,062,293 | +€178,332 | +20.2% |
| Equity | 10/15 | €843,297 | €965,454 | +€122,157 | +14.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €830,897 | €953,054 | +€122,157 | +14.7% |
| Distributable reserves | 133 | €830,897 | €953,054 | +€122,157 | +14.7% |
| Amounts payable | 17/49 | €40,664 | €96,839 | +€56,175 | +138% |
| Amounts payable within one year | 42/48 | €39,910 | €94,903 | +€54,993 | +138% |
| Trade debts | 44 | €7,188 | €8,905 | +€1,717 | +23.9% |
| Suppliers | 440/4 | €7,188 | €8,905 | +€1,717 | +23.9% |
| Taxes, remuneration and social security | 45 | €19,409 | €20,750 | +€1,341 | +6.9% |
| Taxes | 450/3 | €19,409 | €20,750 | +€1,341 | +6.9% |
| Other amounts payable | 47/48 | €13,313 | €65,248 | +€51,935 | +390% |
| Accrued charges and deferred income | 492/3 | €753 | €1,936 | +€1,182 | +157% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €939 | €835 | -€104 | -11.1% |
| Other operating charges | 640/8 | €186 | €186 | = | 0.0% |
| Gross operating margin | 9900 | €263,726 | €281,493 | +€17,767 | +6.7% |
| Operating profit (loss) | 9901 | €262,600 | €280,472 | +€17,871 | +6.8% |
| Financial income | 75/76B | €13,886 | €9,985 | -€3,901 | -28.1% |
| Recurring financial income | 75 | €13,886 | €9,985 | -€3,901 | -28.1% |
| Financial charges | 65/66B | €938 | €2,625 | +€1,687 | +180% |
| Recurring financial charges | 65 | €938 | €2,625 | +€1,687 | +180% |
| Profit (loss) for the period before taxes | 9903 | €275,548 | €287,832 | +€12,284 | +4.5% |
| Income taxes | 67/77 | €84,112 | €88,041 | +€3,930 | +4.7% |
| Profit (loss) for the period | 9904 | €191,436 | €199,790 | +€8,354 | +4.4% |
| Profit (loss) for the period to be appropriated | 9905 | €191,436 | €199,790 | +€8,354 | +4.4% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.